Todd DeVries
Cancer Research And Biostatistics(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, CAR-T cell therapy research, Immunotherapy and Immune Responses, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial(2004)286 cited
- → Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma(2008)184 cited
- → Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome(2015)130 cited
- → JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)(2018)124 cited
- → Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).(2020)122 cited
- → A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer(2015)84 cited
- → Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial(2016)77 cited
- → Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects(2016)60 cited
- → The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period(2000)56 cited
- → A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T(2014)52 cited